A carregar...

Six-Month Open-Label Follow-Up of Risperidone Long-Acting Injection Use in Pediatric Bipolar Disorder

Background: Recent studies suggest that risperidone long-acting injection (RLAI) may be considered for controlling mood episodes in bipolar disorder patients who have relapsed due to medication nonadherence or failure to respond to standard therapies. Currently, no study has reported the usefulness...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Main Authors: Boarati, Miguel A., Wang, Yuan-Pang, Ferreira-Maia, Ana Paula, Cavalcanti, Ana Rosa S., Fu-I, Lee
Formato: Artigo
Idioma:Inglês
Publicado em: Physicians Postgraduate Press, Inc. 2013
Assuntos:
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC3795581/
https://ncbi.nlm.nih.gov/pubmed/24171144
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.4088/PCC.12m01368
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!